Moreover, IKK/NF-κB activation in cardiomyocytes caused significant inflammatory cardiomyopathy and heart failure, while inhibition of the NF-κB signaling pathway by a nondegradable IκBα decreased cardiac hypertrophy and dysfunction induced by Ang II stimuli and pressure overload [25]. Here, NFKBIA is linked to cardiac hypertrophy.